Tag results:
pancreatic cancer
Pancreatic Cell News
A Comparison of 64Cu-Labeled Bi-terminally PEGylated A20FMDV2 Peptides Targeting Integrin ανβ6
[Oncotarget] Researchers described the radiolabeling, in vitro and in vivo evaluation of a bi-terminally PEGylated A20FMDV2 conjugated with DOTA or PCTA for 64Cu radiolabeling.
Pancreatic Cell News
A Two-Phase Approach to Fusicoccane Synthesis to Uncover a Compound That Reduces Tumourigenesis in Pancreatic Cancer Cells
[Angewandte Chemie-International Edition] Scientists generated 15 g of the tricyclic intermediate in 8 steps from ( R )-limonene and 720 mg of the penultimate bioactive intermediate in a protecting-group-free manner.
Pancreatic Cell News
Nanoemulsion-Assisted siRNA Delivery to Modulate the Nervous Tumor Microenvironment in the Treatment of Pancreatic Cancer
[ACS Applied Materials & interfaces] The nanoemulsions exhibited deep tumor penetration that was dependent on exocytosis and enhanced nerve growth factor gene silencing in vitro and in vivo when compared with control polycation/siRNA polyplexes.
Pancreatic Cell News
Effects of Hyperinsulinemia on Pancreatic Cancer Development and the Immune Microenvironment Revealed through Single-Cell Transcriptomics
[Cancer & Metabolism] Scientists performed thorough histopathological analyses and single-cell transcriptomics for both genotypes, Ptf1aCreER;KrasLSL-G12D and sexes.
Pancreatic Cell News
A Novel Chemo-Phenotypic Method Identifies Mixtures of Salpn, Vitamin D3, and Pesticides Involved in the Development of Colorectal and Pancreatic Cancer
[Ecotoxicology and Environmental Safety] Researchers described a novel computational method for characterizing toxicity, associated biological perturbations and disease outcome, called the Chemo-Phenotypic Based Toxicity Measurement. The method was validated in the in vitro, in vivo and organoid models.
Pancreatic Cell News
A Comparison of 64Cu-Labeled Bi-terminally PEGylated A20FMDV2 Peptides Targeting Integrin ανβ6
[Oncotarget] Researchers described the radiolabeling, in vitro and in vivo evaluation of a bi-terminally PEGylated A20FMDV2 conjugated with DOTA or PCTA for 64Cu radiolabeling.